Elmiron
The Elmiron lawsuit involves legal actions taken by individuals who have experienced adverse health effects due to the long-term use of the medication Elmiron (pentosan polysulfate sodium). Elmiron is prescribed to treat interstitial cystitis, a painful bladder condition. The lawsuits claim that the use of Elmiron is linked to serious eye injuries, including a condition called pigmentary maculopathy, which can lead to vision problems and even blindness. Plaintiffs allege that the manufacturer, Janssen Pharmaceuticals (a subsidiary of Johnson & Johnson), failed to adequately warn about the potential eye risks associated with the drug. These lawsuits seek compensation for medical expenses, vision impairment, and other damages. The Elmiron lawsuits highlight concerns about pharmaceutical companies' duty to inform patients about potential side effects, as well as the need for more comprehensive safety testing and monitoring of prescription medications. Below you will find a collection of news articles on this topic.